Takeda Pharmaceutical Company Ltd
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Takeda Pharmaceutical Company Ltd is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Takeda Pharmaceutical Company Ltd in the same report. This provides an indication of potential competitors or associated to Takeda Pharmaceutical Company Ltd. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Zika Virus Infections - Pipeline Review, H2 2016

Zika Virus Infections - Pipeline Review, H2 2016


2016-12-30
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections – Pipeline Review, H2 2016, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape.

Zika virus infection...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8899IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8899IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016

    Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3952CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3952CTIDB
  • View Report: Research and Experts Market Report: Ulcers Global Clinical Trials Review, H2, 2016

    Ulcers Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcers. Report includes...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3951CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3951CTIDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016

    Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3950CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3950CTIDB
  • View Report: Research and Experts Market Report: Constipation Global Clinical Trials Review, H2, 2016

    Constipation Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H2, 2016" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3945CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3945CTIDB
  • View Report: Research and Experts Market Report: Esophageal Diseases Global Clinical Trials Review, H2, 2016

    Esophageal Diseases Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Esophageal Diseases Global Clinical Trials Review, H2, 2016" provides an overview of Esophageal Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3936CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3936CTIDB
  • View Report: Research and Experts Market Report: Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2016

    Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2016" provides an overview of Corrosive Esophagitis (Erosive Esophagitis) clinical trials scenario. This report provides...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3935CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3935CTIDB
  • View Report: Research and Experts Market Report: Gastric Ulcers Global Clinical Trials Review, H2, 2016

    Gastric Ulcers Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastric Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Gastric Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3931CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3931CTIDB
  • View Report: Research and Experts Market Report: Hepatic Injury Global Clinical Trials Review, H2, 2016

    Hepatic Injury Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H2, 2016" provides an overview of Hepatic Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3926CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3926CTIDB
  • View Report: Research and Experts Market Report: Gastritis Global Clinical Trials Review, H2, 2016

    Gastritis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastritis Global Clinical Trials Review, H2, 2016" provides an overview of Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastritis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3925CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3925CTIDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease – Pipeline Review, H2 2016, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

    Parkinson'...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8863IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8863IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or...

    Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016’, provides in depth analysis on Induced Myeloid...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0677TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0677TDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Dengue Fever - Pipeline Review, H2 2016

    Dengue Fever - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever – Pipeline Review, H2 2016, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape.

    Dengue is a mosquito borne infectious...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8836IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8836IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H2 2016

    Hypertension - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

    Hypertension, also referred to as high...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8829IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8829IDB
  • View Report: Research and Experts Market Report: Poliomyelitis - Pipeline Review, H2 2016

    Poliomyelitis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Pipeline Review, H2 2016, provides an overview of the Poliomyelitis (Infectious Disease) pipeline landscape.

    Polio is a highly infectious disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8824IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8824IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Esophageal Varices Global Clinical Trials Review, H2, 2016

    Esophageal Varices Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Esophageal Varices Global Clinical Trials Review, H2, 2016" provides an overview of Esophageal Varices clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3908CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3908CTIDB
  • View Report: Research and Experts Market Report: Esophagitis Global Clinical Trials Review, H2, 2016

    Esophagitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Esophagitis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3905CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3905CTIDB
  • View Report: Research and Experts Market Report: Aneurysm Global Clinical Trials Review, H2, 2016

    Aneurysm Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Aneurysm Global Clinical Trials Review, H2, 2016" provides an overview of Aneurysm clinical trials scenario. This report provides top line data relating to the clinical trials on Aneurysm. Report includes...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3890CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3890CTIDB
  • View Report: Research and Experts Market Report: Bone Metastasis Global Clinical Trials Review, H2, 2016

    Bone Metastasis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2016" provides an overview of Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3880CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3880CTIDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016

    Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016’, provides in depth analysis on Respiratory Syncytial Virus Fusion Protein (RSV F Protein) targeted pipeline therapeutics.

    The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0659TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0659TDB
  • View Report: Research and Experts Market Report: Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016

    Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0654TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0654TDB
  • View Report: Research and Experts Market Report: Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma...

    Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H2 2016’, provides in depth analysis on Bcl-2-Like...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0652TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0652TDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein...

    E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0650TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0650TDB
  • View Report: Research and Experts Market Report: Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0645TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0645TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hand, Foot and Mouth Disease - Pipeline Review, H2 2016

    Hand, Foot and Mouth Disease - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hand, Foot and Mouth Disease - Pipeline Review, H2 2016, provides an overview of the Hand, Foot and Mouth Disease (Infectious Disease) pipeline landscape.

    Hand,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8747IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8747IDB
  • View Report: Research and Experts Market Report: Pilocytic Astrocytoma Global Clinical Trials Review, H2, 2016

    Pilocytic Astrocytoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Pilocytic Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Pilocytic Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3869CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3869CTIDB
  • View Report: Research and Experts Market Report: Angiosarcoma Global Clinical Trials Review, H2, 2016

    Angiosarcoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma....
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3864CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3864CTIDB
  • View Report: Research and Experts Market Report: Renal Stones/Calculi Global Clinical Trials Review, H2, 2016

    Renal Stones/Calculi Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2016" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3860CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3860CTIDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0635TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0635TDB
  • View Report: Research and Experts Market Report: Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog...

    Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016’, provides in depth analysis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0634TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0634TDB
  • View Report: Research and Experts Market Report: Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016

    Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016’, provides in depth analysis on Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0624TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0624TDB
  • View Report: Research and Experts Market Report: Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

    Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016’, provides in depth analysis on Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0620TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0620TDB
  • View Report: Research and Experts Market Report: Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2016

    Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary (Hypogonadotropic) Hypogonadism – Pipeline Review, H2 2016, provides an overview of the Secondary (Hypogonadotropic) Hypogonadism (Male Health) pipeline...
  • Market Report
  • Unassigned
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8736IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8736IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Industry Report: Biotechnology in Asia-Pacific

    Biotechnology in Asia-Pacific


    2016-11-25
    Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Biotechnology
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME8009 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME8009
  • View Report: Research and Experts Industry Report: Biotechnology in Japan

    Biotechnology in Japan


    2016-11-23
    Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-OHME7987 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7987
  • View Report: Research and Experts Market Report: Reperfusion Injury Global Clinical Trials Review, H2, 2016

    Reperfusion Injury Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H2, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3852CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3852CTIDB
  • View Report: Research and Experts Market Report: Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016

    Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3837CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3837CTIDB
  • View Report: Research and Experts Project Profile: Takeda Pharmaceutical Company Limited - Strategy, SWOT and Corporate Finance Report

    Takeda Pharmaceutical Company Limited - Strategy, SWOT and Corporate Finance Report


    2016-12-28
    Takeda Pharmaceutical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and...
  • Project Profile
  • Life Sciences
  • Japan
  • $175.00
  • Report 05IK-D4F92097-A83E-4481-8B27-3F has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-D4F92097-A83E-4481-8B27-3F
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC...

    Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0612TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0612TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016

    Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0603TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0603TDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016

    Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections – Pipeline Review, H2 2016, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious Disease)...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8695IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8695IDB
  • View Report: Research and Experts Market Report: Stem Cell Transplantation Global Clinical Trials Review, H2, 2016

    Stem Cell Transplantation Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2016" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3824CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3824CTIDB
  • View Report: Research and Experts Market Report: Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016

    Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016’, provides in depth analysis on Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0598TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0598TDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H2 2016

    Malaria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

    Malaria is a life-threatening blood disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8670IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8670IDB
  • View Report: Research and Experts Market Report: Muscular Dystrophy - Pipeline Review, H2 2016

    Muscular Dystrophy - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy – Pipeline Review, H2 2016, provides an overview of the Muscular Dystrophy (Musculoskeletal Disorders) pipeline landscape.

    Muscular dystrophy...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8655IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8655IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016

    Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016" provides an overview of Opioid-Induced Bowel Dysfunction (OBD or OIBD) clinical trials scenario. This report provides...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3819CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3819CTIDB
  • View Report: Research and Experts Market Report: Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2016

    Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2016" provides an overview of Gouty Arthritis (Gout) clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3816CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3816CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3813CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3813CTIDB
  • View Report: Research and Experts Market Report: Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016

    Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Tumor Lysis Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3800CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3800CTIDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H2 2016

    Schizophrenia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

    Schizophrenia is a chronic,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8727IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8727IDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2016

    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2016, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8671IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8671IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H2 2016

    Insomnia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insomnia – Pipeline Review, H2 2016, provides an overview of the Insomnia (Central Nervous System) pipeline landscape.

    Insomnia is a sleep disorder that is...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8636IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8636IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma - Pipeline Review, H2 2016

    Burkitt Lymphoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkitt Lymphoma – Pipeline Review, H2 2016, provides an overview of the Burkitt Lymphoma (Oncology) pipeline landscape.

    Burkitt lymphoma is a form of non-Hodgkin�...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8631IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8631IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Bullous Pemphigoid Global Clinical Trials Review, H2, 2016

    Bullous Pemphigoid Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bullous Pemphigoid Global Clinical Trials Review, H2, 2016" provides an overview of Bullous Pemphigoid clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3776CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3776CTIDB
  • View Report: Research and Experts Market Report: Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Pipeline Review, H2 2016

    Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct’s, ‘Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Pipeline Review, H2 2016’, provides in depth analysis on Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0555TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0555TDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Treatment Resistant Depression - Pipeline Review, H2 2016

    Treatment Resistant Depression - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Treatment Resistant Depression – Pipeline Review, H2 2016, provides an overview of the Treatment Resistant Depression (Central Nervous System) pipeline landscape.

    Tr...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8591IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8591IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Rotavirus Infections - Pipeline Review, H2 2016

    Rotavirus Infections - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infections – Pipeline Review, H2 2016, provides an overview of the Rotavirus Infections (Infectious Disease) pipeline landscape.

    Rotavirus is a virus...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8573IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8573IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

    Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections – Pipeline Review, H2 2016, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious Disease)...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8560IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8560IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Gastroenteritis - Pipeline Review, H2 2016

    Gastroenteritis - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis – Pipeline Review, H2 2016, provides an overview of the Gastroenteritis (Gastrointestinal) pipeline landscape.

    Gastroenteritis is an infection...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8558IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8558IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H2 2016

    Major Depressive Disorder - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Major Depressive Disorder – Pipeline Review, H2 2016, provides an overview of the Major Depressive Disorder (Central Nervous System) pipeline landscape.

    Major...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8535IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8535IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...
  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8528IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8528IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Waldenstrom Macroglobulinemia – Pipeline Review, H2 2016, provides an overview of the Waldenstrom Macroglobulinemia (Oncology) pipeline landscape.

    Waldenstrom...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8527IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8527IDB
  • View Report: Research and Experts Market Report: Chikungunya Fever - Pipeline Review, H2 2016

    Chikungunya Fever - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever – Pipeline Review, H2 2016, provides an overview of the Chikungunya Fever (Infectious Disease) pipeline landscape.

    Chikungunya is a viral...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8524IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8524IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2016

    Mild Cognitive Impairment - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment – Pipeline Review, H2 2016, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape.

    Mild...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8518IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8518IDB
  • View Report: Research and Experts Market Report: Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016

    Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016" provides an overview of Perennial Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3764CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3764CTIDB
  • View Report: Research and Experts Market Report: Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016

    Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016" provides an overview of Seasonal Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3763CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3763CTIDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3756CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3756CTIDB
  • View Report: Research and Experts Market Report: Peptic Ulcers Global Clinical Trials Review, H2, 2016

    Peptic Ulcers Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Peptic Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Peptic Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Peptic Ulcers....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3747CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3747CTIDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis Global Clinical Trials Review, H2, 2016

    Ulcerative Colitis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3742CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3742CTIDB
  • View Report: Research and Experts Market Report: Endometriosis Global Clinical Trials Review, H2, 2016

    Endometriosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2016" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3741CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3741CTIDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor...

    Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0548TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0548TDB
  • View Report: Research and Experts Market Report: Lewy body Dementia - Pipeline Review, H2 2016

    Lewy body Dementia - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lewy body Dementia - Pipeline Review, H2 2016’, provides an overview of the Lewy body Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lewy...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8506IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8506IDB
  • View Report: Research and Experts Market Report: Septic Shock - Pipeline Review, H2 2016

    Septic Shock - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H2 2016’, provides an overview of the Septic Shock pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Septic Shock, complete...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8496IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8496IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2016

    Lupus Nephritis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8490IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8490IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

    Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3732CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3732CTIDB
  • View Report: Research and Experts Market Report: Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016

    Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Subependymal Giant Cell Astrocytoma clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3731CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3731CTIDB
  • View Report: Research and Experts Market Report: Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

    Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3730CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3730CTIDB
  • View Report: Research and Experts Market Report: Mycosis Fungoides Global Clinical Trials Review, H2, 2016

    Mycosis Fungoides Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3729CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3729CTIDB
  • View Report: Research and Experts Market Report: Neoplastic Syndrome Global Clinical Trials Review, H2, 2016

    Neoplastic Syndrome Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Neoplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3728CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3728CTIDB
  • View Report: Research and Experts Market Report: Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

    Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of Natural Killer Cell Lymphomas clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3727CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3727CTIDB
  • View Report: Research and Experts Market Report: Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

    Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3726CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3726CTIDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

    Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3725CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3725CTIDB
  • View Report: Research and Experts Market Report: Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016

    Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Fibrous Histiocytoma clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3722CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3722CTIDB
  • View Report: Research and Experts Market Report: T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

    T-Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3718CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3718CTIDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia Global Clinical Trials Review, H2, 2016

    T-Cell Leukemia Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3717CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3717CTIDB
  • View Report: Research and Experts Market Report: Insomnia - Current and Future Players

    Insomnia - Current and Future Players


    2015-02-27
    GlobalData has released its pharma report, “Insomnia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1062FPR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC1062FPR
  • View Report: Research and Experts Market Report: Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

    Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016’, provides in depth analysis on Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0515TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0515TDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8464IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8464IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2016

    Endometriosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8457IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8457IDB
  • View Report: Research and Experts Market Report: Neuromyelitis Optica (Devic

    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2016’, provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8445IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8445IDB
  • View Report: Research and Experts Industry Report: Pharmaceuticals in Japan

    Pharmaceuticals in Japan


    2016-09-26
    Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players includin...
  • Industry Report
  • Pharmaceuticals
  • Japan
  • $350.00
  • Report 05IK-OHME7201 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7201
  • View Report: Research and Experts Market Report: Poxviridae Infections - Pipeline Review, H2 2016

    Poxviridae Infections - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Poxviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Poxviridae Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8429IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8429IDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

    Bone Marrow Transplant Rejection - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8428IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8428IDB
  • View Report: Research and Experts Market Report: Chronic Asthma Global Clinical Trials Review, H2, 2016

    Chronic Asthma Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Chronic Asthma Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3676CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3676CTIDB
  • View Report: Research and Experts Market Report: Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC...

    Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2016’, provides in depth analysis on Mitogen Activated...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0490TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0490TDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H2 2016

    Dyslipidemia - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H2 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8412IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8412IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2016

    Epilepsy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8401IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8401IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8388IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8388IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H2 2016

    Osteoarthritis - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8387IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8387IDB
  • View Report: Research and Experts Market Report: cAMP and cAMP Inhibited cGMP 3

    cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0459TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0459TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

    Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016’, provides an overview of the Influenza A Virus, H3N2 Subtype Infections pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8352IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8352IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8349IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8349IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H2 2016

    Dementia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Dementia - Pipeline Review, H2 2016’, provides an overview of the Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8345IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8345IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H2 2016

    Atopic Dermatitis - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atopic...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8341IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8341IDB
  • View Report: Research and Experts Market Report: Unstable Angina Global Clinical Trials Review, H2, 2016

    Unstable Angina Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Unstable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Unstable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Unstable Angina. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3611CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3611CTIDB
  • View Report: Research and Experts Market Report: Stable Angina Global Clinical Trials Review, H2, 2016

    Stable Angina Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Stable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Stable Angina. Report includes...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3607CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3607CTIDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis Global Clinical Trials Review, H2, 2016

    Arterial Thrombosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Thrombosis Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3590CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3590CTIDB
  • View Report: Research and Experts Market Report: Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016

    Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016" provides an overview of Seasonal Affective Disorder (SAD) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3578CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3578CTIDB
  • View Report: Research and Experts Market Report: Primary Sclerosing Cholangitis - Pipeline Review, H2 2016

    Primary Sclerosing Cholangitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Primary Sclerosing Cholangitis - Pipeline Review, H2 2016’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Primary Sclerosing...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8237IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8237IDB
  • View Report: Research and Experts Market Report: Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016

    Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Focal Adhesion Kinase (FAK or EC 2.7.10.2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Focal Adhesion...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0397TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0397TDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016


    2016-07-20
    ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8278IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8278IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8297IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8297IDB
  • View Report: Research and Experts Company Report: Kowa Company, Ltd. - Strategic SWOT Analysis Review

    Kowa Company, Ltd. - Strategic SWOT Analysis Review


    2016-08-09
    Kowa Company, Ltd. (Kowa) is a global enterprise that develops and manufactures various products. It carries out the manufacturing of over the counter (OTC) products, ethical drugs and medical equipment; import and export of LED lighting equipment, optica...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 01B4-GDPH30783SA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH30783SA
  • View Report: Research and Experts Company Report: Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review

    Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review


    2016-08-09
    Eisai Co., Ltd. (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 01B4-GDPH29032FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH29032FSA
  • View Report: Research and Experts Market Report: Urinary Incontinence - Pipeline Review, H2 2016

    Urinary Incontinence - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H2 2016’, provides an overview of the Urinary Incontinence pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Urinary...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8272IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8272IDB
  • View Report: Research and Experts Market Report: Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2)...

    Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016’, provides in depth analysis on Granulocyte Macrophage...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0385TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0385TDB
  • View Report: Research and Experts Market Report: Smallpox - Pipeline Review, H2 2016

    Smallpox - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Smallpox - Pipeline Review, H2 2016’, provides an overview of the Smallpox pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Smallpox, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8275IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8275IDB
  • View Report: Research and Experts Market Report: Community Acquired Pneumonia - Pipeline Review, H2 2016

    Community Acquired Pneumonia - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Community Acquired Pneumonia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8274IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8274IDB
  • View Report: Research and Experts Market Report: Plague - Pipeline Review, H2 2016

    Plague - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Plague - Pipeline Review, H2 2016’, provides an overview of the Plague pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8273IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8273IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H2 2016

    Sepsis - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8220IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8220IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H2 2016

    Post-Operative Pain - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2016’, provides an overview of the Post-Operative Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Post-Operative...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8219IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8219IDB
  • View Report: Research and Experts Market Report: Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2016

    Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Quadriplegia / Tetraplegia Global Clinical Trials Review, H1, 2016" provides an overview of Quadriplegia / Tetraplegia clinical trials scenario. This report provides top line data relating to the clinical trials on Quadriplegi...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3539CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3539CTIDB
  • View Report: Research and Experts Market Report: Insomnia Global Clinical Trials Review, H1, 2016

    Insomnia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Insomnia Global Clinical Trials Review, H1, 2016" provides an overview of Insomnia clinical trials scenario. This report provides top line data relating to the clinical trials on Insomnia. Report includes an overview...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3533CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3533CTIDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016

    Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Mild...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3523CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3523CTIDB
  • View Report: Research and Experts Market Report: Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016

    Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2)...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0233TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0233TDB
  • View Report: Research and Experts Market Report: Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2016

    Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2016’, provides in depth analysis on Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted pipeline therapeutics....
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0148TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0148TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016

    Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016’, provides in depth analysis on Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) targeted pipeline therapeutics.

    The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0161TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0161TDB
  • View Report: Research and Experts Market Report: Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016

    Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0147TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0147TDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis...

    E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0143TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0143TDB
  • View Report: Research and Experts Market Report: Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review,...

    Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016’, provides in depth analysis on Induced Myeloid Leukemia Cell Differentiation...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0142TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0142TDB
  • View Report: Research and Experts Market Report: Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma...

    Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016’, provides in depth analysis on Bcl-2-Like...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0141TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0141TDB
  • View Report: Research and Experts Market Report: Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016

    Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 2016’, provides in depth analysis on Methionine Aminopeptidase 2 (MAP 2 or Peptidase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0119TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0119TDB
  • View Report: Research and Experts Market Report: Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016

    Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016’, provides in depth analysis on Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0103TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0103TDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7961IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7961IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016

    Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3499CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3499CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

    Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016" provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3495CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3495CTIDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3492CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3492CTIDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3485CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3485CTIDB
  • View Report: Research and Experts Market Report: Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2)...

    Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016’, provides in depth analysis on Granulocyte Macrophage...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0181TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0181TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

    Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.46) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0117TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0117TDB
  • View Report: Research and Experts Market Report: Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

    Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016’, provides in depth analysis on Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0109TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0109TDB
  • View Report: Research and Experts Market Report: Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT...

    Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0105TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0105TDB
  • View Report: Research and Experts Market Report: Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine...

    Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0101TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0101TDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3478CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3478CTIDB
  • View Report: Research and Experts Market Report: Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3474CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3474CTIDB
  • View Report: Research and Experts Market Report: Hyperuricemia Global Clinical Trials Review, H1, 2016

    Hyperuricemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3469CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3469CTIDB
  • View Report: Research and Experts Market Report: Amyloidosis Global Clinical Trials Review, H1, 2016

    Amyloidosis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3467CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3467CTIDB
  • View Report: Research and Experts Market Report: Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016

    Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperphenylalaninemia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3464CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3464CTIDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3444CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3444CTIDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3443CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3443CTIDB
  • View Report: Research and Experts Market Report: Diabetic Retinopathy Global Clinical Trials Review, H1, 2016

    Diabetic Retinopathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3437CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3437CTIDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy Global Clinical Trials Review, H1, 2016

    Diabetic Nephropathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3433CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3433CTIDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016

    Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3423CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3423CTIDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis Global Clinical Trials Review, H1, 2016

    Allergic Rhinitis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H1, 2016" provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3421CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3421CTIDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma Global Clinical Trials Review, H1, 2016

    Follicular Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3418CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3418CTIDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3417CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3417CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016

    Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016’, provides in depth analysis on Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0116TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0116TDB
  • View Report: Research and Experts Market Report: Dengue Fever - Pipeline Review, H1 2016

    Dengue Fever - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Dengue Fever - Pipeline Review, H1 2016’, provides an overview of the Dengue Fever pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dengue Fever, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8163IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8163IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H1 2016

    Colon Cancer - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2016’, provides an overview of the Colon Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colon Cancer, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7965IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7965IDB
  • View Report: Research and Experts Market Report: Medulloblastoma - Pipeline Review, H1 2016

    Medulloblastoma - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2016’, provides an overview of the Medulloblastoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Medulloblastoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8191IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8191IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease - Pipeline Review, H1 2016

    Hand, Foot And Mouth Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H1 2016’, provides an overview of the Hand, Foot And Mouth Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8120IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8120IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma Global Clinical Trials Review, H1, 2016

    Burkitt Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3397CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3397CTIDB
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016

    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016’, provides an overview of the H5N1 Infection (Avian Influenza) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8005IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8005IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016

    Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016’, provides in depth analysis on Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99)...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0043TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0043TDB
  • View Report: Research and Experts Market Report: Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) - Pipeline Review, H1 2016

    Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) - Pipeline Review, H1 2016’, provides in depth analysis on Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0032TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0032TDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome - Pipeline Review, H1 2016

    Irritable Bowel Syndrome - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2016’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8036IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8036IDB
  • View Report: Research and Experts Market Report: Gouty Arthritis (Gout) - Pipeline Review, H1 2016

    Gouty Arthritis (Gout) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2016’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8028IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8028IDB
  • View Report: Research and Experts Market Report: Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016

    Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016’, provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8022IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8022IDB
  • View Report: Research and Experts Market Report: Muscular Dystrophy - Pipeline Review, H1 2016

    Muscular Dystrophy - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Muscular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8016IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8016IDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016

    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Respiratory Syncytial Virus (RSV) Infections pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7992IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7992IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2016

    Malaria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2016’, provides an overview of the Malaria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7969IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7969IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma - Pipeline Review, H1 2016

    Burkitt Lymphoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Burkitt Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Burkitt Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Burkitt Lymphoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8048IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8048IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H1 2016

    Insomnia - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2016’, provides an overview of the Insomnia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Insomnia, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8039IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8039IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Osteosarcoma Global Clinical Trials Review, H1, 2016

    Osteosarcoma Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Osteosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Osteosarcoma....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3389CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3389CTIDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016

    Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016" provides an overview of Waldenstrom Macroglobulinemia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3387CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3387CTIDB
  • View Report: Research and Experts Market Report: Hypothyroidism Global Clinical Trials Review, H1, 2016

    Hypothyroidism Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hypothyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on Hypothyroidism....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3381CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3381CTIDB
  • View Report: Research and Experts Market Report: Osteoporosis Global Clinical Trials Review, H1, 2016

    Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoporosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3378CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3378CTIDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

    Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0001TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0001TDB
  • View Report: Research and Experts Market Report: Guillain-Barre Syndrome - Pipeline Review, H1 2016

    Guillain-Barre Syndrome - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H1 2016’, provides an overview of the Guillain-Barre Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7932IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7932IDB
  • View Report: Research and Experts Market Report: Rotavirus Infections - Pipeline Review, H1 2016

    Rotavirus Infections - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H1 2016’, provides an overview of the Rotavirus Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rotavirus...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7871IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7871IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2016

    Ulcerative Colitis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ulcerative...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7601IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7601IDB
  • View Report: Research and Experts Market Report: Barretts Esophagus Global Clinical Trials Review, H1, 2016

    Barretts Esophagus Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Barretts Esophagus Global Clinical Trials Review, H1, 2016" provides an overview of Barretts Esophagus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3365CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3365CTIDB
  • View Report: Research and Experts Market Report: Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016

    Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016" provides an overview of Vitamin D Deficiency Disorders clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3360CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3360CTIDB
  • View Report: Research and Experts Market Report: Gastroenteritis Global Clinical Trials Review, H1, 2016

    Gastroenteritis Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H1, 2016" provides an overview of Gastroenteritis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroenteritis...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3355CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3355CTIDB
  • View Report: Research and Experts Market Report: Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016

    Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3350CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3350CTIDB
  • View Report: Research and Experts Market Report: Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016

    Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016" provides an overview of Cardiovascular Inflammation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3342CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3342CTIDB
  • View Report: Research and Experts Market Report: Gastroenteritis - Pipeline Review, H1 2016

    Gastroenteritis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Gastroenteritis - Pipeline Review, H1 2016’, provides an overview of the Gastroenteritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastroenteritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7915IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7915IDB
  • View Report: Research and Experts Market Report: Chikungunya - Pipeline Review, H1 2016

    Chikungunya - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chikungunya - Pipeline Review, H1 2016’, provides an overview of the Chikungunya pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chikungunya, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7843IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7843IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2016

    Mild Cognitive Impairment - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7841IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7841IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7840IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7840IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H1 2016

    Major Depressive Disorder - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2016’, provides an overview of the Major Depressive Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7826IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7826IDB
  • View Report: Research and Experts Market Report: H1N1 Infection - Pipeline Review, H1 2016

    H1N1 Infection - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2016’, provides an overview of the H1N1 Infection pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for H1N1 Infection,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7819IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7819IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7688IDB
  • View Report: Research and Experts Market Report: Hyperuricemia - Pipeline Review, H1 2016

    Hyperuricemia - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H1 2016’, provides an overview of the Hyperuricemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperuricemia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7898IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7898IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2016

    Lupus Nephritis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7856IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7856IDB
  • View Report: Research and Experts Market Report: Septic Shock - Pipeline Review, H1 2016

    Septic Shock - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H1 2016’, provides an overview of the Septic Shock pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Septic Shock, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7849IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7849IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2016

    Depression - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2016’, provides an overview of the Depression pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Depression, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7581IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7581IDB
  • View Report: Research and Experts Market Report: Neuromyelitis Optica (Devic

    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2016’, provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7740IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7740IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2016

    Endometriosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7713IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7713IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016

    Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3319CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3319CTIDB
  • View Report: Research and Experts Industry Report: Pharmaceuticals in Japan

    Pharmaceuticals in Japan


    2015-12-11
    Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players includin...
  • Industry Report
  • Pharmaceuticals
  • Japan
  • $350.00
  • Report 05IK-OHME4827 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME4827
  • View Report: Research and Experts Industry Report: Biotechnology in Asia-Pacific

    Biotechnology in Asia-Pacific


    2016-01-18
    Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Biotechnology
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME5100 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME5100
  • View Report: Research and Experts Industry Report: Biotechnology in Japan

    Biotechnology in Japan


    2016-01-18
    Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-OHME4829 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME4829
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2016

    Osteoarthritis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7811IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7811IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7744IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7744IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2016

    Dyslipidemia - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7652IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7652IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H1 2016

    Epilepsy - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7565IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7565IDB
  • View Report: Research and Experts Market Report: Cancer Pain Global Clinical Trials Review, H1, 2016

    Cancer Pain Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3297CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3297CTIDB
  • View Report: Research and Experts Market Report: Duodenal Ulcer Global Clinical Trials Review, H1, 2016

    Duodenal Ulcer Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, H1, 2016" provides an overview of Duodenal Ulcer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3286CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3286CTIDB
  • View Report: Research and Experts Market Report: Asthma Global Clinical Trials Review, H1, 2016

    Asthma Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2016" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3281CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3281CTIDB
  • View Report: Research and Experts Market Report: Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016

    Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Zollinger-Ellison Syndrome (Gastrinoma) clinical trials scenario. This report provides top line...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3276CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3276CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hodgkin

    OpportunityAnalyzer: Hodgkin's Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Hodgkin’s lymphoma (HL), or Hodgkin’s disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all new cancer cases, but overall...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC052POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC052POA
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016

    Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016" provides an overview of Obstructive Pulmonary Disease clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3249CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3249CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Initially considered a curable disease due to substantial sensitivity to first-line chemotherapies, small cell lung cancer (SCLC) remains a fatal disease with poor outcomes due to high relapse rates, with the majority of patients surviving one year or...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC055POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC055POA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Company Report: Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile

    Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Report
  • Medical Devices
  • Japan
  • $250.00
  • Report 05IB-GDME27458D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME27458D
  • View Report: Research and Experts Market Report: Amyloidosis - Pipeline Review, H1 2016

    Amyloidosis - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2016’, provides an overview of the Amyloidosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7646IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7646IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7562IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7562IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7659IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7659IDB
  • View Report: Research and Experts Market Report: Smallpox - Pipeline Review, H1 2016

    Smallpox - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Smallpox - Pipeline Review, H1 2016’, provides an overview of the Smallpox pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Smallpox, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7643IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7643IDB
  • View Report: Research and Experts Market Report: Community Acquired Pneumonia - Pipeline Review, H1 2016

    Community Acquired Pneumonia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Community Acquired Pneumonia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7633IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7633IDB
  • View Report: Research and Experts Market Report: Plague - Pipeline Review, H1 2016

    Plague - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Plague - Pipeline Review, H1 2016’, provides an overview of the Plague pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7629IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7629IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H1 2016

    Sepsis - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7672IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7672IDB
  • View Report: Research and Experts Market Report: Primary Sclerosing Cholangitis - Pipeline Review, H1 2016

    Primary Sclerosing Cholangitis - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H1 2016’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7591IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7591IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H1 2016

    Post-Operative Pain - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2016’, provides an overview of the Post-Operative Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Post-Operative...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7548IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7548IDB
  • View Report: Research and Experts Market Report: Reperfusion Injury Global Clinical Trials Review, H1, 2016

    Reperfusion Injury Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H1, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3238CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3238CTIDB
  • View Report: Research and Experts Market Report: Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016

    Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3229CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3229CTIDB
  • View Report: Research and Experts Market Report: Sezary Syndrome Global Clinical Trials Review, H1, 2016

    Sezary Syndrome Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3210CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3210CTIDB
  • View Report: Research and Experts Market Report: Hemostasis Global Clinical Trials Review, H1, 2016

    Hemostasis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2016" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3209CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3209CTIDB
  • View Report: Research and Experts Company Report: Alcami Corp - Strategic SWOT Analysis Review

    Alcami Corp - Strategic SWOT Analysis Review


    2016-12-20
    Alcami Corp (Alcami), formerly AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML) is contract development and manufacturing company (CDMO) that offers a comprehensive range of pharmaceutical development and manufacturing services to...
  • Company Report
  • Life Sciences
  • United States
  • $300.00
  • Report 05IC-GDPH1000046SA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH1000046SA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019

    OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019


    2015-12-01
    The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated by OTC laxatives set to undergo substantial growth between 2014 and 2019. The main drivers of growth will be an increase in the diagnosed OIC population....
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC007EPOA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC007EPOA
  • View Report: Research and Experts Market Report: Dengue Fever Global Clinical Trials Review, H1, 2016

    Dengue Fever Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Dengue Fever Global Clinical Trials Review, H1, 2016" provides an overview of Dengue Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3194CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3194CTIDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2015

    Epilepsy - Pipeline Review, H2 2015


    2015-11-11
    Epilepsy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7401IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7401IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015

    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015


    2015-10-30
    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2015’, provides an overview of the Idiopathic (Essential) Hypertension’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7256IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7256IDB
  • View Report: Research and Experts Market Report: Chikungunya - Pipeline Review, H2 2015

    Chikungunya - Pipeline Review, H2 2015


    2015-10-30
    Chikungunya - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chikungunya - Pipeline Review, H2 2015’, provides an overview of the Chikungunya’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7238IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7238IDB
  • View Report: Research and Experts Market Report: Septic Shock - Pipeline Review, H2 2015

    Septic Shock - Pipeline Review, H2 2015


    2015-10-30
    Septic Shock - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H2 2015’, provides an overview of the Septic Shock’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7234IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7234IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H2 2015

    Overactive Bladder - Pipeline Review, H2 2015


    2015-10-30
    Overactive Bladder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7219IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7219IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H2 2015

    Post-Operative Pain - Pipeline Review, H2 2015


    2015-10-28
    Post-Operative Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7286IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7286IDB
  • View Report: Research and Experts Market Report: Rotavirus Infections - Pipeline Review, H2 2015

    Rotavirus Infections - Pipeline Review, H2 2015


    2015-10-21
    Rotavirus Infections - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H2 2015’, provides an overview of the Rotavirus Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7246IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7246IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2015

    Endometriosis - Pipeline Review, H2 2015


    2015-10-21
    Endometriosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6846IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6846IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H2 2015

    Brain Cancer - Pipeline Review, H2 2015


    2015-10-21
    Brain Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6838IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6838IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015


    2015-10-14
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6856IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6856IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H2 2015

    Sepsis - Pipeline Review, H2 2015


    2015-09-30
    Sepsis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2015’, provides an overview of the Sepsis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7072IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7072IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: H1N1 Infection - Pipeline Review, H2 2015

    H1N1 Infection - Pipeline Review, H2 2015


    2015-09-23
    H1N1 Infection - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H2 2015’, provides an overview of the H1N1 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7078IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7078IDB
  • View Report: Research and Experts Market Report: Poxvirus Infections - Pipeline Review, H2 2015

    Poxvirus Infections - Pipeline Review, H2 2015


    2015-09-16
    Poxvirus Infections - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Poxvirus Infections - Pipeline Review, H2 2015’, provides an overview of the Poxvirus Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7130IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7130IDB
  • View Report: Research and Experts Market Report: Neuromyelitis Optica (Devic

    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2015


    2015-09-16
    Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2015’, provides an overview of the Neuromyelitis Optica (Devic’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7128IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7128IDB
  • View Report: Research and Experts Market Report: H3N2 Infection - Pipeline Review, H2 2015

    H3N2 Infection - Pipeline Review, H2 2015


    2015-09-16
    H3N2 Infection - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘H3N2 Infection - Pipeline Review, H2 2015’, provides an overview of the H3N2 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7110IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7110IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015


    2015-08-26
    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6999IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6999IDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease - Pipeline Review, H2 2015

    Hand, Foot And Mouth Disease - Pipeline Review, H2 2015


    2015-08-12
    Hand, Foot And Mouth Disease - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2015’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7035IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7035IDB
  • View Report: Research and Experts Market Report: Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Chronic Plaque Psoriasis - Pipeline Review, H2 2015


    2015-07-31
    Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6862IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6862IDB
  • View Report: Research and Experts Market Report: Dengue - Pipeline Review, H2 2015

    Dengue - Pipeline Review, H2 2015


    2015-07-15
    Dengue - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Dengue - Pipeline Review, H2 2015’, provides an overview of the Dengue’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6817IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6817IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2015


    2015-06-30
    Parkinson's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6562IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6562IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2015

    Malaria - Pipeline Review, H1 2015


    2015-06-30
    Malaria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6677IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6677IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2015

    Tuberculosis - Pipeline Review, H1 2015


    2015-06-30
    Tuberculosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6566IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6566IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Skin And Soft Tissue Infections - Pipeline Review, H1 2015

    Skin And Soft Tissue Infections - Pipeline Review, H1 2015


    2015-06-30
    Skin And Soft Tissue Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Skin And Soft Tissue Infections - Pipeline Review, H1 2015’, provides an overview of the Skin And Soft Tissue Infections’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6488IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6488IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H1 2015

    Atopic Dermatitis - Pipeline Review, H1 2015


    2015-06-30
    Atopic Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Atopic Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6513IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6513IDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015

    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015


    2015-06-30
    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015’, provides an overview of the Respiratory Syncytial Virus...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6574IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6574IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2015

    Osteoporosis - Pipeline Review, H1 2015


    2015-06-30
    Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6572IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6572IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015

    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015


    2015-06-24
    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015’, provides an overview of the Attention Deficit Hyperactivity...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6693IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6693IDB
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015


    2015-06-24
    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015’, provides an overview of the H5N1 Infection (Avian Influenza)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6689IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6689IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome - Pipeline Review, H1 2015

    Irritable Bowel Syndrome - Pipeline Review, H1 2015


    2015-06-17
    Irritable Bowel Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2015’, provides an overview of the Irritable Bowel Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6702IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6702IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H1 2015

    Insomnia - Pipeline Review, H1 2015


    2015-06-10
    Insomnia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2015’, provides an overview of the Insomnia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6711IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6711IDB
  • View Report: Research and Experts Market Report: Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015


    2015-06-10
    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015’, provides an overview of the Bipolar Disorder (Manic Depression)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6704IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6704IDB
  • View Report: Research and Experts Market Report: Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015

    Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015


    2015-06-10
    Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015’, provides an overview of the Leishmaniasis (Kala-Azar)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6703IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6703IDB
  • View Report: Research and Experts Market Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015

    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015


    2015-05-29
    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015’, provides an overview of the Gastrointestinal Stromal Tumor (GIST)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6594IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6594IDB
  • View Report: Research and Experts Market Report: Gouty Arthritis (Gout) - Pipeline Review, H1 2015

    Gouty Arthritis (Gout) - Pipeline Review, H1 2015


    2015-05-29
    Gouty Arthritis (Gout) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2015’, provides an overview of the Gouty Arthritis (Gout)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6585IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6585IDB
  • View Report: Research and Experts Market Report: Muscular Dystrophy - Pipeline Review, H1 2015

    Muscular Dystrophy - Pipeline Review, H1 2015


    2015-05-29
    Muscular Dystrophy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Muscular Dystrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6529IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6529IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H1 2015

    Overactive Bladder - Pipeline Review, H1 2015


    2015-05-29
    Overactive Bladder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6525IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6525IDB
  • View Report: Research and Experts Market Report: Sjogren

    Sjogren's Syndrome - Pipeline Review, H1 2015


    2015-05-20
    Sjogren's Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sjogren's Syndrome - Pipeline Review, H1 2015’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6744IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6744IDB
  • View Report: Research and Experts Market Report: Guillain-Barre Syndrome - Pipeline Review, H1 2015

    Guillain-Barre Syndrome - Pipeline Review, H1 2015


    2015-05-13
    Guillain-Barre Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H1 2015’, provides an overview of the Guillain-Barre Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6770IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6770IDB
  • View Report: Research and Experts Market Report: Chikungunya - Pipeline Review, H1 2015

    Chikungunya - Pipeline Review, H1 2015


    2015-04-30
    Chikungunya - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chikungunya - Pipeline Review, H1 2015’, provides an overview of the Chikungunya’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6543IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6543IDB
  • View Report: Research and Experts Market Report: Septic Shock - Pipeline Review, H1 2015

    Septic Shock - Pipeline Review, H1 2015


    2015-04-30
    Septic Shock - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H1 2015’, provides an overview of the Septic Shock’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6539IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6539IDB
  • View Report: Research and Experts Market Report: Hyperuricemia - Pipeline Review, H1 2015

    Hyperuricemia - Pipeline Review, H1 2015


    2015-04-29
    Hyperuricemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H1 2015’, provides an overview of the Hyperuricemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6615IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6615IDB
  • View Report: Research and Experts Market Report: Rotavirus Infections - Pipeline Review, H1 2015

    Rotavirus Infections - Pipeline Review, H1 2015


    2015-04-29
    Rotavirus Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H1 2015’, provides an overview of the Rotavirus Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6552IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6552IDB
  • View Report: Research and Experts Market Report: Gastroenteritis - Pipeline Review, H1 2015

    Gastroenteritis - Pipeline Review, H1 2015


    2015-04-22
    Gastroenteritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastroenteritis - Pipeline Review, H1 2015’, provides an overview of the Gastroenteritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6643IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6643IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H1 2015

    Sepsis - Pipeline Review, H1 2015


    2015-03-31
    Sepsis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2015’, provides an overview of the Sepsis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6245IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6245IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015


    2015-03-31
    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015’, provides an overview of the Idiopathic (Essential) Hypertension’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6418IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6418IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015

    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015


    2015-03-19
    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015’, provides an overview of the Chronic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6455IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6455IDB
  • View Report: Research and Experts Market Report: H1N1 Infection - Pipeline Review, H1 2015

    H1N1 Infection - Pipeline Review, H1 2015


    2015-03-19
    H1N1 Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2015’, provides an overview of the H1N1 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6251IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6251IDB
  • View Report: Research and Experts Market Report: Dermatitis - Pipeline Review, H1 2015

    Dermatitis - Pipeline Review, H1 2015


    2015-03-19
    Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6240IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6240IDB
  • View Report: Research and Experts Market Report: Human Papillomavirus Infections - Pipeline Review, H1 2015

    Human Papillomavirus Infections - Pipeline Review, H1 2015


    2015-03-11
    Human Papillomavirus Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Human Papillomavirus Infections - Pipeline Review, H1 2015’, provides an overview of the Human Papillomavirus Infections’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6254IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6254IDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015


    2015-02-28
    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6268IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6268IDB
  • View Report: Research and Experts Market Report: H3N2 Infection - Pipeline Review, H1 2015

    H3N2 Infection - Pipeline Review, H1 2015


    2015-02-24
    H3N2 Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘H3N2 Infection - Pipeline Review, H1 2015’, provides an overview of the H3N2 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6284IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6284IDB
  • View Report: Research and Experts Market Report: Poxvirus Infections - Pipeline Review, H1 2015

    Poxvirus Infections - Pipeline Review, H1 2015


    2015-02-18
    Poxvirus Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Poxvirus Infections - Pipeline Review, H1 2015’, provides an overview of the Poxvirus Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6304IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6304IDB
  • View Report: Research and Experts Market Report: Neuromyelitis Optica (Devic

    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2015


    2015-02-18
    Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Neuromyelitis Optica (Devic’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6302IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6302IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease - Pipeline Review, H1 2015

    Hand, Foot And Mouth Disease - Pipeline Review, H1 2015


    2015-01-30
    Hand, Foot And Mouth Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H1 2015’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6213IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6213IDB
  • View Report: Research and Experts Market Report: Women Infertility - Pipeline Review, H1 2015

    Women Infertility - Pipeline Review, H1 2015


    2015-01-30
    Women Infertility - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2015’, provides an overview of the Women Infertility’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6133IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6133IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015


    2015-01-30
    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015’, provides an overview of the Chronic Obstructive Pulmonary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6009IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6009IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015


    2015-01-30
    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6177IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6177IDB
  • View Report: Research and Experts Market Report: Memory Impairment - Pipeline Review, H1 2015

    Memory Impairment - Pipeline Review, H1 2015


    2015-01-30
    Memory Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Memory Impairment - Pipeline Review, H1 2015’, provides an overview of the Memory Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6157IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6157IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2015

    Depression - Pipeline Review, H1 2015


    2015-01-30
    Depression - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6011IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6011IDB
  • View Report: Research and Experts Market Report: Community Acquired Pneumonia - Pipeline Review, H1 2015

    Community Acquired Pneumonia - Pipeline Review, H1 2015


    2015-01-22
    Community Acquired Pneumonia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2015’, provides an overview of the Community Acquired Pneumonia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6088IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6088IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2015

    Ulcerative Colitis - Pipeline Review, H1 2015


    2015-01-22
    Ulcerative Colitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6015IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6015IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H1 2015

    Post-Operative Pain - Pipeline Review, H1 2015


    2015-01-22
    Post-Operative Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6116IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6116IDB
  • View Report: Research and Experts Market Report: Helicobacter Pylori Infections - Pipeline Review, H1 2015

    Helicobacter Pylori Infections - Pipeline Review, H1 2015


    2015-01-22
    Helicobacter Pylori Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Helicobacter Pylori Infections - Pipeline Review, H1 2015’, provides an overview of the Helicobacter Pylori Infections’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6065IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6065IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015


    2015-01-22
    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral Neuropathy (Sensory...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6055IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6055IDB
  • View Report: Research and Experts Market Report: Chronic Plaque Psoriasis - Pipeline Review, H1 2015

    Chronic Plaque Psoriasis - Pipeline Review, H1 2015


    2015-01-22
    Chronic Plaque Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6048IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6048IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015


    2015-01-22
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6042IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6042IDB
  • View Report: Research and Experts Market Report: Pertussis - Pipeline Review, H1 2015

    Pertussis - Pipeline Review, H1 2015


    2015-01-22
    Pertussis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2015’, provides an overview of the Pertussis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6035IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6035IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2015

    Endometriosis - Pipeline Review, H1 2015


    2015-01-22
    Endometriosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6032IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6032IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H1 2015

    Brain Cancer - Pipeline Review, H1 2015


    2015-01-22
    Brain Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6024IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6024IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2015

    Dyslipidemia - Pipeline Review, H1 2015


    2015-01-22
    Dyslipidemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6020IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6020IDB
  • View Report: Research and Experts Market Report: Dengue - Pipeline Review, H1 2015

    Dengue - Pipeline Review, H1 2015


    2015-01-22
    Dengue - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dengue - Pipeline Review, H1 2015’, provides an overview of the Dengue’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6019IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6019IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Report: Kowa Company, Ltd. - Strategic SWOT Analysis Review

    Kowa Company, Ltd. - Strategic SWOT Analysis Review


    2016-08-09
    Kowa Company, Ltd. (Kowa) is a global enterprise that develops and manufactures various products. It carries out the manufacturing of over the counter (OTC) products, ethical drugs and medical equipment; import and export of LED lighting equipment, optica...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH30783SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH30783SA
  • View Report: Research and Experts Company Report: Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review

    Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review


    2016-08-09
    Eisai Co., Ltd. (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH29032FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH29032FSA
  • View Report: Research and Experts Company Report: Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review

    Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review


    2016-09-07
    Daiichi Sankyo Company, Limited (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs,...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH5751FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH5751FSA
  • View Report: Research and Experts Company Report: Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review

    Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review


    2016-09-20
    Shionogi & Co., Ltd., (Shionogi) is a pharmaceutical company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products and other related products for the treatment of disorders in the areas of metabolism, infec...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH2619FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH2619FSA
  • View Report: Research and Experts Company Report: Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review

    Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Nippon Kayaku Co., Ltd. (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UV-curing...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH31776FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH31776FSA
  • View Report: Research and Experts Company Report: XenoPort, Inc. (XNPT) - Financial and Strategic SWOT Analysis Review

    XenoPort, Inc. (XNPT) - Financial and Strategic SWOT Analysis Review


    2016-07-19
    XenoPort, Inc. (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structu...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH8427FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH8427FSA
  • View Report: Research and Experts Company Report: Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review

    Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Takeda Pharmaceutical Company Limited (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH7835FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH7835FSA
  • View Report: Research and Experts Company Report: GTx, Inc. (GTXI) - Financial and Strategic SWOT Analysis Review

    GTx, Inc. (GTXI) - Financial and Strategic SWOT Analysis Review


    2016-05-17
    GTx, Inc. (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers and other serious medical conditio...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH29790FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH29790FSA
  • View Report: Research and Experts Company Report: Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

    Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH27458FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH27458FSA
  • View Report: Research and Experts Company Report: Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review

    Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review


    2016-05-03
    Celldex Therapeutics, Inc. (Celldex) is a bio-pharmaceutical company. It undertakes the discovery, development and commercialization of vaccines and targeted immunotherapy technologies for the treatment of cancer and other devastating diseases. The compan...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH57234FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH57234FSA
  • View Report: Research and Experts Company Report: Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review

    Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review


    2016-04-19
    Vivus Inc. (Vivus) is a biopharmaceutical company which undertakes the development and commercialization of next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's product portfolio includes...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH34078FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH34078FSA
  • View Report: Research and Experts Company Report: Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review

    Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Chugai Pharmaceutical Co., Ltd. (Chugai) is a subsidiary of Hoffmann-La Roche Ltd which focus on the manufacturing marketing, import and export of new pharmaceutical products. The company's product portfolio focuses on various therapeutic areas inclu...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH28303FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH28303FSA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review

    F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review


    2016-10-12
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company that provides biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its products include medicines to treat cancers, brain diseases, viral and bacterial...
  • Company Report
  • Life Sciences
  • Switzerland
  • $125.00
  • Report 05IC-GDPH756FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH756FSA
  • View Report: Research and Experts Market Report: Leiomyoma Global Clinical Trials Review, H2, 2015

    Leiomyoma Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Leiomyoma Global Clinical Trials Review, H2, 2015" provides an overview of Leiomyoma clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyoma. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2991CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC2991CTIDB
  • View Report: Research and Experts Market Report: Asthma Global Clinical Trials Review, H2, 2015

    Asthma Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H2, 2015" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2984CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC2984CTIDB
  • View Report: Research and Experts Market Report: Premature Ovarian Failure Global Clinical Trials Review, H2, 2015

    Premature Ovarian Failure Global Clinical Trials Review, H2, 2015


    2015-12-09
    GlobalData's clinical trial report, “Premature Ovarian Failure Global Clinical Trials Review, H2, 2015" provides an overview of Premature Ovarian Failure clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3053CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3053CTIDB
  • View Report: Research and Experts Industry Report: Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

    Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities


    2015-02-28
    After years of buoyant growth, the pharmaceutical industry is facing up to a more challenging time. With the growing cost of developing novel drugs, combined with rising regulatory pressures, the use of lifecycle management is playing an ever-more importa...
  • Industry Report
  • Cosmetics and Personal Care
  • Global
  • $2,795.00
  • Report 01GZ-CS1005IS has a star rating of 3.5 out of 5
  • Go to More information on Report 01GZ-CS1005IS
  • View Report: Research and Experts Industry Report: Europe Markets for Wound and Tissue Management - 15 Countries (2011-2021)

    Europe Markets for Wound and Tissue Management - 15 Countries (2011-2021)


    2015-07-01
    The European wound and tissue management market includes moist, antimicrobial and interactive wound dressings, negative pressure wound therapy, bandages, wound closure devices, hemostats, tissue sealants and anti-adhesion products. These products treat...
  • Industry Report
  • Blood and Tissue Supply
  • Europe
  • $9,995.00
  • Report 01EK-iDATA_EUWT15_RPT has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUWT15_RPT
  • View Report: Research and Experts Company Report: Takeda Pharmaceutical Company Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

    Takeda Pharmaceutical Company Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


    2012-11-30
    ICD Research's "Takeda Pharmaceutical Company Limited: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview,...
  • Company Report
  • Pharmaceuticals
  • Japan
  • $125.00
  • Report 01H3-SW1931CP has a star rating of 2.4 out of 5
  • Go to More information on Report 01H3-SW1931CP
  • Industries and Sectors

    • Infectious Disease... (18)
    • Oncology (46)
    • Gastrointestinal... (18)
    • Immunology (8)
    • Central Nervous... (15)
    • Pharmaceuticals (133)
    • Cardiovascular (7)
    • Genitourinary Disorders... (1)
    • Unassigned (3)
    • Biotechnology (4)
    • Life Sciences (117)
    • Musculoskeletal... (1)
    • Healthcare (11)
    • Metabolic Disorders... (5)
    • Dermatology (2)
    • Respiratory (3)
    • Iron and steel Construction... (19)
    • Medical Devices (2)
    • Cosmetics and Personal... (1)
    • Blood and Tissue... (1)

    Geographic Regions

    • Global (388)
    • Asia Pacific (2)
    • Japan (17)
    • Switzerland (2)
    • United States (5)
    • Europe (1)

    Report Types

    • Market Report (387)
    • Industry Report (8)
    • Project Profile (1)
    • Company Report (19)

    Return to Company List

    Page created and rendered - Cache updated [4.00051s]